Medicare will pay for COVID-19 antibody infusions

by on

Many providers and suppliers will be able to bill Medicare to deliver antibody therapies to treat COVID-19, as the FDA approved emergency use of one treatment.

Many providers and suppliers will be able to bill Medicare to deliver antibody therapies to treat COVID-19, as the FDA approved emergency use of one treatment.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: